Daniel E. Everitt

57 papers receiving 4.5k citations

Daniel E. Everitt's Hit Papers

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis 2022 · 355 citations
3550+2+4Years since publication200400600

Peers

Daniel E. Everitt
Comparison fields: 5 of 146
  • Infectious Diseases 1.9k
  • Geriatrics and Gerontology 176
  • Epidemiology 1.1k
  • Ophthalmology 245
  • Immunology 590
Replace Chantal Csajka with:
Chantal Csajka Switzerland
Swu‐Jane Lin United States
Feng Zhou China
Mary H. H. Ensom Canada
Fabio Barra Italy
Catia Marzolini Switzerland
Simone Ferrero Italy
Joseph T. DiPiro United States
Youqin Yan China
Victoria Cornelius United Kingdom
Daniel E. Everitt relative to Chantal Csajka Switzerland Chantal Csajka's profile →
Citations per field
00.5×2×4×6×7.9×
Chantal Csajka · 1×
Citations per year

Countries citing papers authored by Daniel E. Everitt

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Everitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Everitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Everitt more than expected).

Fields of papers citing papers by Daniel E. Everitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Everitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Everitt. The network helps show where Daniel E. Everitt may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel E. Everitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel E. Everitt Line = papers co-authored together Daniel E. Everitt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Hit paper breakdown →
2020729
2 2012368
3
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
Hit paper breakdown →
2022355
4 1992324
5 1993244
6 2004227
7 2015204
8 2015184
9 2006180
10 1989166
11 2007159
12 1991134
13 2019105
14 200792
15 199092
16 199080
17 198676
18 199571
19 202060
20 199859

About Daniel E. Everitt

Daniel E. Everitt is a scholar working on Infectious Diseases, Epidemiology, Ophthalmology, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 57 papers that have together received 4.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (18 papers), Pneumonia and Respiratory Infections (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Glaucoma and retinal disorders (5 papers), Mycobacterium research and diagnosis (4 papers), Geriatric Care and Nursing Homes (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). The work is most often cited by research in Infectious Diseases (1.9k citations), Geriatrics and Gerontology (176 citations), Epidemiology (1.1k citations), Ophthalmology (245 citations) and Immunology (590 citations). Daniel E. Everitt has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Jerry Avorn, Carl M. Mendel, Christo van Niekerk, Melvin Spigelman, Andreas Henri Diacon, Rodney Dawson, Mary Ann Mascelli, Amour Venter, Stephen B. Soumerai and Florian von Groote-Bidlingmaier. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The International Journal of Tuberculosis and Lung Disease, The Journal of Clinical Pharmacology, Journal of the American Geriatrics Society and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact